Deciphera Pharmaceuticals, Inc. Banner Image

Deciphera Pharmaceuticals, Inc.

  • Ticker DCPH
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Deciphera Pharmaceuticals, Inc. Logo Image
  • 201-500 Employees
  • Based in Waltham, Massachusetts
Deciphera is a biopharmaceutical company focused on discovering, developing and commercializing important new medicines to improve the lives of people with cancer. They are leveraging their proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advancing multiple product candidates fromMore their platform in clinical studies, QINLOCKTM is Deciphera’s FDA-approved switch-control kinase inhibitor for the treatment of fourth-line gastrointestinal stromal tumor (GIST). QINLOCK is also approved for fourth-line GIST in Canada and Australia.
Deciphera Pharmaceuticals, Inc.

Most Recent Annual Report

Deciphera Pharmaceuticals, Inc.
MOST RECENT 2021 Annual Report and Form 10K

Older/Archived Annual Reports